Product Highlight - Emgality
01 Dec 2020
More migraine-headache-free days.1 Rapid onset and sustained responses.2,3
The only agent with pre-specified 50%/75%/100% response rates among the class2
Rapid onset at Week 1 and sustained response through Month 62,3
Consistently maintains efficacy from week to week between monthly dosing4
Well-tolerated with low discontinuation rates comparable to placebo5
The loading dose for Emgality gives patients a bold start to treatment that won’t require titration or dose adjustments2
References:
1. Skljarevski V, et al. Cephalalgia. 2018;38(8):1442-1454.
2. Emgality Prescribing Information Hong Kong.
3. Detke HC, Millen BA, Zhang Q, et al. Rapid onset of effect of galcanezumab for the prevention of episodic migraine: analysis of the EVOLVE studies. Headache. 2019;60(2):348-359.
4. Samaan K, Pozo-Rosich P, Nicholson R, Rathmann S, Pearlman E. Consistency of galcanezumab efficacy throughout a month over time. IHC 2019 Late Breaking Abstracts. Cephalalgia. 2019;39(IS):358-427. 5. Bangs et al. BMC Neurology (2020) 20:25.
ELI LILLY ASIA, INC.
Unit 3203-3206, 32/F, Chubb Tower, Windsor House, 311 Gloucester Road, Causeway Bay, Hong Kong
• Tel: (+852) 2572 0160 • Fax: (+852) 2572 7893 • Website: www.lilly.com.hk
The only agent with pre-specified 50%/75%/100% response rates among the class2
Rapid onset at Week 1 and sustained response through Month 62,3
Consistently maintains efficacy from week to week between monthly dosing4
Well-tolerated with low discontinuation rates comparable to placebo5
The loading dose for Emgality gives patients a bold start to treatment that won’t require titration or dose adjustments2
References:
1. Skljarevski V, et al. Cephalalgia. 2018;38(8):1442-1454.
2. Emgality Prescribing Information Hong Kong.
3. Detke HC, Millen BA, Zhang Q, et al. Rapid onset of effect of galcanezumab for the prevention of episodic migraine: analysis of the EVOLVE studies. Headache. 2019;60(2):348-359.
4. Samaan K, Pozo-Rosich P, Nicholson R, Rathmann S, Pearlman E. Consistency of galcanezumab efficacy throughout a month over time. IHC 2019 Late Breaking Abstracts. Cephalalgia. 2019;39(IS):358-427. 5. Bangs et al. BMC Neurology (2020) 20:25.
ELI LILLY ASIA, INC.
Unit 3203-3206, 32/F, Chubb Tower, Windsor House, 311 Gloucester Road, Causeway Bay, Hong Kong
• Tel: (+852) 2572 0160 • Fax: (+852) 2572 7893 • Website: www.lilly.com.hk
